Auna SA

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF: $110M normalized FCF base (roughly half of $232.7M TTM EBITDA to reflect heavy hospital-network expansion capex); 7% annual FCF growth years 1-5; 4% years 6-10; 12% discount rate (EM leverage/political risk); 3% terminal growth; $970.5M net debt subtracted; 74.01M shares outstanding.

Reasoning: Auna is a fast-growing but heavily levered Latin American integrated healthcare operator (oncology, cardiology, reproductive health) still investing in new hospital capacity, so a conservative normalized-FCF DCF with an EM-appropriate discount rate better reflects sustainable equity value than trailing EBITDA or reported FCF alone.